Biopharma Insights

Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads

New research commissioned by ArisGlobal, a provider of life sciences technology solutions, reveals that surging regulatory workloads are forcing life …

Continue ›››

What will be the key trends in AI innovation in the Pharmaceutical Industry in 2025?

The pharmaceutical industry is undergoing transformation thanks to artificial intelligence (AI) in particular GenAI. From drug discovery and manufacturing to …

Continue ›››

Cautious Optimism in 2024 for Healthcare M&A

2024 was supposed to mark the start of a significant comeback for healthcare mergers and acquisitions (M&A). Yet with the …

Continue ›››

AI Is Key to Democratizing Drug Discovery

The global drug development landscape is bustling, with over 20,000 biotechs competing for investor attention. Now more than ever, having …

Continue ›››

Key Trends in Aging Research: Where Are We Now?

Over the past decade, aging research has transitioned from foundational biological studies, including a landmark introduction of 9 hallmarks of …

Continue ›››

Global Pharma R&D Investments Surpass $276 Billion Annually, Exceeding Previous Estimates

A recent study, titled Comprehensive Measurement of Biopharmaceutical R&D Investment, published in Nature Reviews Drug Discovery, reveals that global pharmaceutical …

Continue ›››

The Promise of Chatbots in Clinical Trials

In the rapidly changing field of clinical trials, chatbots are becoming valuable tools for data analysis. These AI-driven conversational agents …

Continue ›››

Even 10 Minutes Matter in Cancer Research

A recent study conducted by Indivumed Therapeutics highlights a crucial, yet often overlooked, factor in cancer research: the cold ischemia …

Continue ›››

How Enterprise Architecture is Powering Digital Transformation in Healthcare

The healthcare industry is confronting critical challenges including a systemic labour shortage, rising costs (estimated to grow to its highest …

Continue ›››

UK-based Laverock Therapeutics Expands Gene-Silencing Technology to Tackle Multiple Disease Areas

Laverock Therapeutics, a UK company based at the Stevenage Bioscience Catalyst, is advancing its programmable gene-silencing platform, GEiGS, aimed at …

Continue ›››

Microbiome, Aging, and the Synthetic Immune System: A New Frontier in Geroscience

What does aging have in common with pathogens like bacteria and viruses? And how does the quest to tackle antimicrobial …

Continue ›››

How AI Makes Telehealth for STIs Smarter and More Accessible

In a recent WHO report, Director-General Dr. Tedros Ghebreyesus raised concerns about the global STI epidemic saying, “HIV, viral hepatitis, …

Continue ›››